Evidence map›Paper›PMID 30778522›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Seroprotection at Different Levels of the Healthcare System After Routine Vaccination With Diphtheria-Tetanus-Pertussis whole cell-Hepatitis B-Haemophilus influenzae Type B in Lao People's Democratic Republic.

Lisa Hefele, Sengdavanh Syphan, Dalouny Xayavong, Anousin Homsana, Daria Kleine, Phetsavanh Chanthavilay, Phonethipsavanh Nouanthong, Kinnaly Xaydalasouk, Outavong Phathammavong, Somxay Billamay and 4 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lisa HefeleLao-Lux Laboratory, Institut Pasteur du Laos, Vientiane, Lao People's Democratic Republic.
Sengdavanh SyphanInstitut de la Francophonie pour la Médecine Tropicale, Vientiane, Lao People's Democratic Republic.
Dalouny XayavongInstitut de la Francophonie pour la Médecine Tropicale, Vientiane, Lao People's Democratic Republic.
Anousin HomsanaInstitut de la Francophonie pour la Médecine Tropicale, Vientiane, Lao People's Democratic Republic.
Daria KleineLao-Lux Laboratory, Institut Pasteur du Laos, Vientiane, Lao People's Democratic Republic.
Phetsavanh ChanthavilayInstitut de la Francophonie pour la Médecine Tropicale, Vientiane, Lao People's Democratic Republic.
Phonethipsavanh NouanthongLao-Lux Laboratory, Institut Pasteur du Laos, Vientiane, Lao People's Democratic Republic.
Kinnaly XaydalasoukLao-Lux Laboratory, Institut Pasteur du Laos, Vientiane, Lao People's Democratic Republic.
Outavong PhathammavongLuxembourg Development Cooperation Agency, Vientiane, Lao People's Democratic Republic.
Somxay BillamayChildren Hospital, Vientiane, Lao People's Democratic Republic.
Anonh XeuatvongsaExpanded Programme on Immunisation, Vientiane, Lao People's Democratic Republic.
Daniel ReinharzInstitut de la Francophonie pour la Médecine Tropicale, Vientiane, Lao People's Democratic Republic.
Claude P MullerLao-Lux Laboratory, Institut Pasteur du Laos, Vientiane, Lao People's Democratic Republic.
Antony P BlackInstitut de la Francophonie pour la Médecine Tropicale, Vientiane, Lao People's Democratic Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Lao People's Democratic Republic continues to sustain a considerable burden of vaccine-preventable diseases because of incomplete vaccine coverage and weak vaccine responses. We have assessed seroconversion after routine vaccination with the pentavalent vaccine to capture weaknesses of vaccine management at the different levels of the healthcare system.

methodsA total of 1151 children (aged 8-28 months) with 3 documented doses of the pentavalent vaccine delivered at central hospitals in Vientiane and the provincial hospital, 3 district hospitals, and 10 health centers in Bolikhamxay province were enrolled. Sociodemographic information was collected with a standardized questionnaire. Serum samples were analyzed for antibodies against vaccine components, and bivariate and multivariable analyses were performed to identify risk factors for low vaccine responses.

resultsSeroprotection rates at the provincial, district, and health center level were as high as in central hospitals, but seroprotection rates in areas covered by remote health centers were significantly lower. Protective levels also rapidly decreased with age at sampling. Seroprotection rates in Bolikhamxay against the different components reached 70%-77% and were up to 20% higher than in previous studies in the same region; 18.8% more children received the hepatitis B vaccine birth dose and the hepatitis B virus infection rate was 4 times lower.

conclusionsVaccine immunogenicity has dramatically improved in a central province, likely due to training and investment in the cold chain. Nevertheless, there remains a need to focus on the "last mile" in remote areas were most children are vaccinated through outreach activities.

Indexed as

Communicable Disease ControlDelivery of Health CareDiphtheria-Tetanus-Pertussis VaccineHaemophilus VaccinesHepatitis B VaccinesAntibodies, BacterialAntibodies, ViralChild, PreschoolFemaleHumansImmunogenicity, VaccineInfantLaosMaleOutcome Assessment, Health CarePublic Health SurveillanceAntibodies, BacterialAntibodies, ViralDiphtheria-Tetanus-Pertussis VaccineHaemophilus VaccinesHepatitis B VaccinesVaccines, Combineddiphtheriahepatitis Bimmunogenicitytetanusvaccination

Identifiers

PMID30778522
PMCPMC6880335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.